Genomic & Biopharma News

Spark R&D chief High exits in wake of Roche takeover
Spark Therapeutics co-founder and R&D head Kathy High has left the gene therapy specialist in the wake of its takeover by Roche. The Basel-based Big Pharma talked up its ability to cope with the loss of the R&D chief, pointing to the 450-person team High helped build to back up its confidence.
Fierce Biotech, 2020-02-21 11:18:21

Axion Announces Porsche Prize at Pittcon 2020
What do a Porsche and Axion have in common? The experience of a lifetime.
News Medical Life Sciences, 2020-02-21 11:17:00

Opdivo/Yervoy continues to impress in kidney cancer
The results represent the longest follow-up with any immuno-oncology–based therapy in previously untreated RCC patients.
PharmaTimes, 2020-02-21 11:12:17

GSK, Immatics team up for cancer cell therapies
Under the terms of the agreement, Immatics will receive an upfront payment of $45m.
PharmaTimes, 2020-02-21 11:04:41

NHS staff still face ‘unacceptable’ abuse from public
NHS leaders have confirmed that from April, NHS services will be able to protect staff by barring from non-emergency care any patient or visitor who inflicts discriminatory or harassing behaviour on staff.
PharmaTimes, 2020-02-21 10:58:12

ORB relocates to Deerfield Beach and celebrates grand opening of new facility with local researchers
After 8 years of operation in Palm Beach Gardens, Ocean Ridge Biosciences (ORB) has recently relocated to a 5,394 sq. ft. facility in Deerfield Beach, Florida. The new facility provides several improvements which will enable ORB to provide improved and expanded services to academic and corporate clients. These include:
ORB Company Blog, 2016-11-21 19:26:55

Teva’s Austedo flunks in late-stage paediatric Tourette study
Compared to placebo, the drug didn’t achieve significant reduction in motor and phonic tics.
PharmaTimes, 2020-02-21 10:54:27

Using 'mini-brains' to detect harmful neurodevelopmental effects of antidepressant
Researchers at Johns Hopkins Bloomberg School of Public Health have demonstrated the use of stem-cell-derived "mini-brains" to detect harmful side effects of a common drug on the developing brain.
News Medical Life Sciences, 2020-02-21 09:26:09

ORB relocates to Deerfield Beach and celebrates grand opening of new facility with local researchers
After 8 years of operation in Palm Beach Gardens, Ocean Ridge Biosciences (ORB) has recently relocated to a 5,394 sq. ft. facility in Deerfield Beach, Florida. The new facility provides several improvements which will enable ORB to provide improved and expanded services to academic and corporate clients. These include:
ORB Company Blog, 2016-11-21 19:26:55

Genfit's NASH key phase 3 data delayed
Genfit’s shares were in the red Friday morning after the French biotech announced it was delaying a data readout for its potential blockbuster fatty liver hopeful elafibranor.
Fierce Biotech, 2020-02-21 09:03:01

Isolating Single T-cells of Interest using an Optofluidic Platform
Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.
News Medical Life Sciences, 2020-02-21 08:35:13